Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Recruiting now
Conditions studied: Non-Small Cell Lung Cancer
In brief
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.
Key facts
- Study ID
- NCT06626243
- Run by
- Scientific Institute San Raffaele
- People needed
- 140
- Starts
- 2024-09-30
- Expected to finish
- 2025-10-15
- Last updated by the study team
- 2024-11-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of clinical or pathological stage IIB (T1-2, hilar N1, M0) and III (any T, N1-2, M0) NSCLC surgically treated with robotic, VATS and open approach with radical intent from 1st of January 2016 to 31st of March 2024
- Received neoadjuvant chemo-immunotherapy or immunotherapy alone
- Age >= 18 years old at the moment of surgery
You may not qualify if…
- Age <18 years old at the moment of surgery
Where it is running
- Baptist Health South Florida — Miami, Florida, United States (enrolling)
- Memorial Sloan Kettering Cancer Center — New York, New York, United States (enrolling)
- West Virginia University — Morgantown, West Virginia, United States (enrolling)
- Istituto Clinico Humanitas — Rozzano, Milan, Italy (enrolling)
- Scientific Institute Ospedale San Raffaele — Milan, Italy (enrolling)
- Regina Elena National Cancer Institute — Rome, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.